• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项关于563例患者完全植入式静脉输液港维护及并发症的回顾性观察研究:延长冲洗间隔与缩短冲洗间隔的比较

A retrospective observational study on maintenance and complications of totally implantable venous access ports in 563 patients: Prolonged versus short flushing intervals.

作者信息

Zhang Yuejiao, Zhao Ruiyi, Jiang Nan, Shi Yun, Wang Qianmi, Sheng Ye

机构信息

Nursing Department, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.

出版信息

Int J Nurs Sci. 2021 Jun 4;8(3):252-256. doi: 10.1016/j.ijnss.2021.05.005. eCollection 2021 Jul 10.

DOI:10.1016/j.ijnss.2021.05.005
PMID:34307772
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8283705/
Abstract

OBJECTIVES

To assess whether the extension of the flushing interval will increase risks of complications associated with totally implantable venous access port (TIVAP) in the off-treatment period.

METHODS

A retrospective single-center observational study was performed. Patients with a TIVAP in the off-treatment period that underwent regular flushing in our clinic were included. Data concerning patients and their TIVAPs were recorded. Patient baseline characteristics and TIVAP-related complications were analyzed. Continuous variables were analyzed by ANOVA or the Kruskal-Wallis test. To compare the occurrence of TIVAP-related complications, the chi-square test was used; if needed, Fisher's exact test was used.

RESULTS

Totally 607 patients were reviewed, and 563 patients were finally included. Thirteen complications were recorded, including 11 cases of catheter occlusion (1.95%), one case of port cannula rotation (0.18%), and one case of catheter tip malposition (0.18%). No device-related infection or venous thrombosis was recorded. Among these patients, the average flushing interval was 35.27 ± 13.09 days. Patients were divided into three groups according to the flushing interval: every 28 days or less (Group 1,  = 133); every 29-44 days (Group 2,  = 350); and every 45 days or more (Group 3,  = 80). No significant difference in catheter-related complications was found among the three groups ( > 0.05).

CONCLUSIONS

In the TIVAP off-treatment period, patients without any history of TIVAP-related complications during approximately one year can attempt to prolong the flushing interval to more than 4 weeks; we further suggest that 5-6 weeks may be an appropriate option for these patients.

摘要

目的

评估在非治疗期延长冲管间隔时间是否会增加完全植入式静脉输液港(TIVAP)相关并发症的风险。

方法

进行一项回顾性单中心观察性研究。纳入在我院门诊接受定期冲管的非治疗期TIVAP患者。记录患者及其TIVAP的相关数据。分析患者基线特征和TIVAP相关并发症。连续变量采用方差分析或Kruskal-Wallis检验进行分析。为比较TIVAP相关并发症的发生率,采用卡方检验;必要时,采用Fisher精确检验。

结果

共纳入607例患者进行评估,最终563例患者纳入研究。记录到13例并发症,包括11例导管堵塞(1.95%)、1例输液港套管旋转(0.18%)和1例导管尖端位置异常(0.18%)。未记录到与装置相关的感染或静脉血栓形成。这些患者的平均冲管间隔时间为35.27±13.09天。根据冲管间隔时间将患者分为三组:每28天或更短(第1组,=133);每29 - 44天(第2组,=350);每45天或更长(第3组,=80)。三组之间导管相关并发症无显著差异(>0.05)。

结论

在TIVAP非治疗期,近一年无TIVAP相关并发症病史的患者可尝试将冲管间隔时间延长至4周以上;我们进一步建议5 - 6周可能是这些患者的合适选择。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3e6/8283705/100e39dd983e/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3e6/8283705/100e39dd983e/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3e6/8283705/100e39dd983e/gr1.jpg

相似文献

1
A retrospective observational study on maintenance and complications of totally implantable venous access ports in 563 patients: Prolonged versus short flushing intervals.一项关于563例患者完全植入式静脉输液港维护及并发症的回顾性观察研究:延长冲洗间隔与缩短冲洗间隔的比较
Int J Nurs Sci. 2021 Jun 4;8(3):252-256. doi: 10.1016/j.ijnss.2021.05.005. eCollection 2021 Jul 10.
2
Safety and feasibility assessment of extending the flushing interval in totally implantable venous access port flushing during the non-treatment stage for patients with breast cancer.乳腺癌患者非治疗阶段完全植入式静脉输液港冲管间隔延长的安全性与可行性评估
Front Oncol. 2022 Dec 2;12:1021488. doi: 10.3389/fonc.2022.1021488. eCollection 2022.
3
Comparison of methods for the microbiological diagnosis of totally implantable venous access port-related infections.完全植入式静脉输液港相关感染的微生物学诊断方法比较。
J Med Microbiol. 2020 Nov;69(11):1273-1284. doi: 10.1099/jmm.0.001263. Epub 2020 Oct 16.
4
Safety of immediate use of totally implantable venous access ports in adult patients with cancer: a retrospective single-center study.成年癌症患者立即使用完全植入式静脉输液港的安全性:一项回顾性单中心研究。
Korean J Clin Oncol. 2021 Dec;17(2):104-110. doi: 10.14216/kjco.21016. Epub 2021 Dec 31.
5
Catheter malposition analysis of totally implantable venous access port in breast cancer patients.乳腺癌患者完全植入式静脉输液港导管位置不当分析
Front Surg. 2023 Jan 6;9:1061826. doi: 10.3389/fsurg.2022.1061826. eCollection 2022.
6
Standardized procedure prevents perioperative and early complications in totally implantable venous-access ports-a complication analysis of more than 1000 TIVAP implantations.标准化程序可预防完全植入式静脉输液港的围手术期和早期并发症——1000 多例 TIVAP 植入术的并发症分析。
Langenbecks Arch Surg. 2022 Dec;407(8):3755-3762. doi: 10.1007/s00423-022-02656-9. Epub 2022 Sep 7.
7
[Totally implantable venous access ports: frequency of complications and analysis of bacterial contamination after ablation].[完全植入式静脉通路端口:消融术后并发症发生率及细菌污染分析]
Pathol Biol (Paris). 2004 Dec;52(10):566-74. doi: 10.1016/j.patbio.2004.07.020.
8
Late complications associated with totally implantable venous access port implantation via the internal jugular vein.经颈内静脉植入全植入式静脉输液港的晚期并发症。
Support Care Cancer. 2020 Jun;28(6):2761-2768. doi: 10.1007/s00520-019-05122-3. Epub 2019 Nov 14.
9
Safety of 3-month flushing interval for prevention of occlusion in totally implantable venous access ports: An analysis focused on intraluminal clots.预防完全植入式静脉通路端口堵塞的3个月冲洗间隔的安全性:一项聚焦于管腔内血栓的分析。
J Vasc Access. 2024 Oct 14:11297298241282822. doi: 10.1177/11297298241282822.
10
Perioperative and Postoperative Complications of Supraclavicular, Ultrasound-Guided, Totally Implantable Venous Access Port via the Brachiocephalic Vein in Adult Patients: A Retrospective Multicentre Study.成人患者经头臂静脉行锁骨上超声引导下完全植入式静脉通路端口的围手术期和术后并发症:一项回顾性多中心研究
Ther Clin Risk Manag. 2021 Feb 4;17:137-144. doi: 10.2147/TCRM.S292230. eCollection 2021.

引用本文的文献

1
[Clinical Practice and Quality Control Guidelines for Totally Implantable Venous Access Ports in Cancer Patients (2024)].《癌症患者完全植入式静脉输液港临床实践与质量控制指南(2024年)》
Sichuan Da Xue Xue Bao Yi Xue Ban. 2025 Mar 20;56(2):400-410. doi: 10.12182/20250360602.
2
Evaluation of the efficacy of totally implantable venous access port in breast cancer patients undergoing chemotherapy.完全植入式静脉输液港在乳腺癌化疗患者中的疗效评估
Discov Oncol. 2025 Mar 24;16(1):383. doi: 10.1007/s12672-025-02020-5.
3
Is it feasible to prolong the flushing interval for totally implantable venous access devices (TIVADs)? A systematic review and meta-analysis.

本文引用的文献

1
Safety and feasibility of 3-month interval access and flushing for maintenance of totally implantable central venous port system in colorectal cancer patients after completion of curative intended treatments.根治性治疗完成后,每 3 个月进行一次全植入式中心静脉港系统的通道开放和冲洗,用于维持结直肠癌患者的治疗,评估其安全性和可行性。
Medicine (Baltimore). 2021 Jan 15;100(2):e24156. doi: 10.1097/MD.0000000000024156.
2
Prolonging the flush-lock interval of totally implantable venous access ports in patients with cancer: A systematic review and meta-analysis.延长癌症患者全植入式静脉输液港的冲洗锁定间隔:系统评价和荟萃分析。
J Vasc Access. 2021 Sep;22(5):814-821. doi: 10.1177/1129729820950998. Epub 2020 Sep 1.
3
延长完全植入式静脉通路装置(TIVADs)的冲洗间隔是否可行?一项系统评价和荟萃分析。
Int J Clin Oncol. 2025 Jan;30(1):40-50. doi: 10.1007/s10147-024-02665-2. Epub 2024 Nov 27.
4
A Study on the Effect of Lidocaine-Assisted Non-Coring Needle Placement Using Painless Encircling Puncture in Children with Totally Implantable Venous Access Device.利多卡因辅助非芯针置入法采用无痛环绕穿刺在完全植入式静脉通路装置儿童中的效果研究
J Multidiscip Healthc. 2024 May 16;17:2313-2320. doi: 10.2147/JMDH.S459786. eCollection 2024.
5
Central venous access device terminologies, complications, and reason for removal in oncology: a scoping review.肿瘤学中中央静脉通路装置的术语、并发症和移除原因:范围综述。
BMC Cancer. 2024 Apr 19;24(1):498. doi: 10.1186/s12885-024-12099-8.
6
Silver-Mixed Port Reduces Venous Access Port Related Infection Rate Compared to Non-Silver-mixed Port: A Single-center Retrospective Analysis.银混合端口比非银混合端口降低静脉接入端口相关感染率:一项单中心回顾性分析。
Cardiovasc Intervent Radiol. 2023 Dec;46(12):1696-1702. doi: 10.1007/s00270-023-03583-y. Epub 2023 Oct 30.
7
Exploring risk factors for totally implantable venous access devices (TIVADs)-related thrombotic occlusion in the off-treatment period.探讨治疗期结束后完全植入式静脉通路装置(TIVAD)相关血栓性闭塞的危险因素。
Sci Rep. 2023 Jul 4;13(1):10767. doi: 10.1038/s41598-023-37902-7.
8
Safety and feasibility assessment of extending the flushing interval in totally implantable venous access port flushing during the non-treatment stage for patients with breast cancer.乳腺癌患者非治疗阶段完全植入式静脉输液港冲管间隔延长的安全性与可行性评估
Front Oncol. 2022 Dec 2;12:1021488. doi: 10.3389/fonc.2022.1021488. eCollection 2022.
Implanting totally implantable venous access ports in the upper arm is feasible and safe for patients with early breast cancer.
对于早期乳腺癌患者,在上臂植入全植入式静脉通路端口是可行且安全的。
J Vasc Access. 2020 Sep;21(5):609-614. doi: 10.1177/1129729819894461. Epub 2019 Dec 16.
4
Complications of central venous port systems: a pictorial review.中心静脉端口系统的并发症:图文综述
Insights Imaging. 2019 Aug 28;10(1):86. doi: 10.1186/s13244-019-0770-2.
5
Effects of prolonged flushing interval in totally implantable venous access devices (TIVADs).完全植入式静脉通路装置(TIVADs)中延长冲洗间隔的影响。
Br J Nurs. 2018 Apr 26;27(8):S4-S10. doi: 10.12968/bjon.2018.27.8.S4.
6
Totally implantable venous access ports: a prospective long-term study of early and late complications in adult patients with cancer.完全植入式静脉通路端口:成年癌症患者早期和晚期并发症的前瞻性长期研究
Support Care Cancer. 2018 Jan;26(1):81-89. doi: 10.1007/s00520-017-3816-3. Epub 2017 Jul 29.
7
Effects of heparin catheter-sealing solution for implantable venous access ports on D-dimer levels in older cancer patients.肝素封管液对老年癌症患者植入式静脉输液港中 D-二聚体水平的影响。
Eur Rev Med Pharmacol Sci. 2017 Jul;21(3 Suppl):97-101.
8
Comparison of three types of central venous catheters in patients with malignant tumor receiving chemotherapy.三种中心静脉导管在接受化疗的恶性肿瘤患者中的比较。
Patient Prefer Adherence. 2017 Jul 12;11:1197-1204. doi: 10.2147/PPA.S142556. eCollection 2017.
9
Totally Implantable Venous Access Devices: A Review of Complications and Management Strategies.完全植入式静脉通路装置:并发症及管理策略综述
Am J Clin Oncol. 2017 Feb;40(1):94-105. doi: 10.1097/COC.0000000000000361.
10
Phase II Trial on Extending the Maintenance Flushing Interval of Implanted Ports.关于延长植入式端口维护冲洗间隔的II期试验。
J Oncol Pract. 2017 Jan;13(1):e22-e28. doi: 10.1200/JOP.2016.010843. Epub 2016 Oct 23.